INTRAVENOUS IMMUNOGLOBULIN AND ITS COMPLICATIONS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

MOHAMMADZADEH I.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF BABOL UNIVERSITY OF MEDICAL SCIENCES (JBUMS) Year:2011 | Volume:13 | Issue:3 (60) Page(s): 80-89

Download Full-Text

Persian Verion

View:

737

Download:

Cites:

Information Journal Paper

Title

INTRAVENOUS IMMUNOGLOBULIN AND ITS COMPLICATIONS

Author(s)

MOHAMMADZADEH I. | Issue Writer Certificate

Keywords

INTRAVENOUS IMMUNOGLOBULINQ3

CHILDRENQ3

COMPLICATIONSQ3

Abstract

INTRAVENOUS IMMUNOGLOBULIN (IVIG) is a safe biological product used in many cases, such as primary and secondary immune deficiency, infectious diseases, critically ill patients and autoimmune disorders. IVIG has many advantages compared with intramuscular immunoglobulin and is obtained from pooled plasma of 10.000-60.000 donors. Today, IVIG use in clinical settings has increased. Despite its use in many diseases, FDA only has approved its use in patients suffering from ITP, primary immunodeficiency, pediatric HIV, Kawasaki disease, bone marrow transplantation and B-cells chronic lymphocytic leukemia. But, it has been used for other cases like Guillain–Barré syndrome, premature infants, critically ill patients admitted to ICU, severe asthma and uncontrolled seizures which FDA had not approved yet.This biological product affects immune deficiency and autoimmune diseases in different ways. Despite the relative safety of this product, the patient may experience mild but acute COMPLICATIONS.In most cases acute reaction is due to high speed infusion rate which is mild but systemic side effects in the form of allergic and non-allergic anaphylaxis are seen, especially in patients with CVID and IgA selective deficiency. The patient should be under medical supervision during infusion and to deal with anaphylaxis shock, facilities should be available.Today, the subcutaneous type of immunoglobulin is used at home under supervision of a nurse and the patient satisfaction is high, because of its lower cost and also it does not need hospital admission.

Cites

No record.

References

No record.

Cite

APA: Copy

MOHAMMADZADEH, I.. (2011). INTRAVENOUS IMMUNOGLOBULIN AND ITS COMPLICATIONS. JOURNAL OF BABOL UNIVERSITY OF MEDICAL SCIENCES (JBUMS), 13(3 (60)), 80-89. SID. https://sid.ir/paper/73251/en

Vancouver: Copy

MOHAMMADZADEH I.. INTRAVENOUS IMMUNOGLOBULIN AND ITS COMPLICATIONS. JOURNAL OF BABOL UNIVERSITY OF MEDICAL SCIENCES (JBUMS)[Internet]. 2011;13(3 (60)):80-89. Available from: https://sid.ir/paper/73251/en

IEEE: Copy

I. MOHAMMADZADEH, “INTRAVENOUS IMMUNOGLOBULIN AND ITS COMPLICATIONS,” JOURNAL OF BABOL UNIVERSITY OF MEDICAL SCIENCES (JBUMS), vol. 13, no. 3 (60), pp. 80–89, 2011, [Online]. Available: https://sid.ir/paper/73251/en

Related Journal Papers